发明名称 TREATMENT OF ALZHEIMER DISEASE BY MODULATION OF SYNAPSINS.
摘要 The role of synapsin II in both the reformation and the maintenance of synaptic connections in cultured hippocampal neurons can be the basis of therapy for neurodegenerative disorder, particularly Alzheimer disease, which involve the disruption of synapses. When synapsin II expression in neurons is blocked by antisense synapsin II oligonucleotides, the ability of hippocampal neurons to reform as well as to maintain synapses is severely disrupted. Antisense suppression of synapsin II after axon formation but immediately before synaptogenesis prevents synapse formation. Suppression of synapsin II after synaptogenesis disrupts the majority of existing synapses. Re-expression of synapsin II in synapsin deficient neurons achieved after removing the antisense oligonucleotides leads to the re-establishment of synaptic connections, providing direct evidence that synapsin II is required for the maintenance and/or restoration of synapses. Thus, therapeutic methods based on the reformation and the maintenance of synapses, including delivery of the synapsin cDNAS or proteins into the patient's nervous system, use of the synapsin cDNAS to promote the synapse forming ability of cells for grafting, and use of agents that increase the expression of, enhancing the activity of, or mimic the activity of, the endogenous synapsins, can provide treatment of neurodegenerative disorders.
申请公布号 MX9708736(A) 申请公布日期 1998.06.28
申请号 MX19970008736 申请日期 1997.11.12
申请人 THE ROCKEFELLER UNVERSITY;BRIGHAM AND WOMEN'S HOSPITAL 发明人 HUI-QUAN HAN;PAUL GREENGARD;KENNETH S. KOSIK;ADRIANA FERREIRA
分类号 A61K45/00;A61K31/465;A61K31/565;A61K31/7052;A61K38/00;A61K38/18;A61K38/22;A61P25/00;A61P25/28;(IPC1-7):A61K38/18;A61K31/70 主分类号 A61K45/00
代理机构 代理人
主权项
地址